Modulators of 5-ht receptors and methods of use thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of m-g1 and -NO2, applied in the modulator of 5-HT receptor and its application field, can solve the problems of limiting treatment efficacy, affecting patient cooperation, primary negative and cognitive symptom recognition, etc.
Inactive Publication Date: 2012-05-30
ABBVIE INC +1
View PDF9 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0009] A further complication of the symptoms of schizophrenia is the appearance of drug-induced so-called secondary negative symptoms and cognitive deficits, which are difficult to recognize from primary negative and cognitive symptoms [Remington G and Kapur S (2
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 42
[0606] Example 42 significantly and dose-dependently attenuated AMP-induced hyperactivity (main effect F(3,29)=6.2, Pfigure 1 ).
[0607] Example 181 administered to animals at 1.0 and 3.0 mg / kg before AMP significantly and in a dose-dependent manner attenuated AMP-induced hyperactivity (main effect F(7,29)=11.5, P Figure 2a ). In addition, no effect of Example 181 was seen in the spontaneous activity ( Figure 2b ).
[0608] Example 169 given to animals at 10 and 30 mg / kg before AMP; significantly and in a dose-dependent manner attenuated AMP-induced hyperactivity (main effect F(7,29)=12.6, P Figure 3a ). In addition, no effect of Example 169 was seen in the spontaneous activity ( Figure 3b ).
Embodiment 2
[0609] Example 2 significantly and in a dose-dependent manner weakened PCP-induced hyperactivity (main effect F(4,26)=3.5, P Figure 4 ).
[0610] d. Methods of Using Compounds
[0611] The compound of the present invention is 5-HT 2C receptor or 5-HT 6 receptor modulator or 5-HT 2C and 5-HT 6 Modulator of both receptors. In certain embodiments of the invention, the compound of formula (I) is 5-HT 2C Agonists and partial agonists of receptors or 5-HT 6 receptor antagonists. In certain other embodiments of the invention, the compound of formula (I) is 5-HT 2C Agonists and partial agonists of receptors and 5-HT 6 receptor antagonists. Thus, such compounds are useful in the prevention or treatment of 5-HT 2C and 5-HT 6 It is of interest in disease conditions in which either or both receptors are involved. Accordingly, the present invention provides methods of preventing or treating such conditions in a subject in need thereof. A subject in need of treatment thereof ma...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present application relates to 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,4]benzodiazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,5]benzodiazepine, 2,3,4,4a,5,6,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1]benzazepine, 1,2,3,4,4a,5-hexahydro-7H-pyrazino[1,2-a][4,1]benzoxazepine, and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[2,1-d][1,5]benzoxazepine, and 5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4]diazepine derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, X1, X2, X3, X4, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
Description
[0001] Cross References to Related Applications [0002] This patent application claims priority from US Provisional Patent Application 61 / 171,912, filed April 23, 2009, the entire contents of which are incorporated herein by reference. technical field [0003] The present invention relates to 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,4]benzodiazepine, 1,2, 3,4,4a,5,6,7-Octahydropyrazino[1,2-a][1,5]benzodiazepine, 2,3,4,4a,5,6 ,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a,5,6,7-octahydropyridine Azino[1,2-a][1]benzazepine, 1,2,3,4,4a,5-hexahydro-7H-pyrazino[1,2-a][4 ,1]benzoxazepine, and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[2,1-d][1,5]benzoxy Azapine, and 5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4 ]diazepine derivatives, including these 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,4]benzodiazepines Heterene, 1,2,3,4,4a,5,6,7-Octahydropyrazino[1,2-a][1,5]benzodiazepine, 2 ,3,4,4a,5,6,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more